相关实验视频
Updated: Jun 29, 2025

06:15
Preparation of Binary and Ternary Deep Eutectic Systems
Published on: October 31, 2019
11.9K
在有氧条件下,在深层阳性溶剂中,对塔克林和胆酶抑制剂的可持续合成方法
Luciana Cicco1, Filippo Maria Perna1, Vito Capriati1
1Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, Consorzio Interuniversitario Nazionale "Metodologie e Processi Innovativi di Sintesi" (C.I.N.M.P.I.S.), Via E. Orabona 4, I-70125 Bari, Italy.
Molecules (Basel, Switzerland)
|March 28, 2024
概括
一种新的绿色合成方法使用环保的深层环氧溶剂 (DESs),达到98%的产量. 这种可持续的方法具有可扩展性,并产生毒性较低的塔克林衍生物.
科学领域:
- 绿色化学 绿色化学
- 药用化学 医学化学
- 药物开发 药物开发
背景情况:
- 塔克林是一种用于治疗阿尔茨海默病的药物.
- 塔克林的传统合成方法涉及挥发性有机化合物 (VOC),造成环境和健康风险.
- 需要更可持续,更有效的药物合成协议.
研究的目的:
- 开发一种增强的,可持续的,高效的合成方法,用于塔克林及其衍生物.
- 用环保型溶剂取代危险的挥发性有机化合物 (VOC).
- 探索新型塔克林衍生物的合成,降低肝毒性.
主要方法:
- 开发了一种新型的合成协议,用于使用深层欧性溶剂 (DESs) 合成塔克林.
- 为可扩展性和产量优化反应条件.
- 合成了基于三醇的新型塔克林衍生物,通过在DESs中整合in situ亚利化制剂.
主要成果:
- 通过使用DESs实现了98%的塔克林合成产量.
- 优化的协议显示了可扩展性,最高可达3g,没有产量损失.
- 合成了基于三醇的新型塔克林衍生物,产量为90-95%,肝毒性降低.
- 量化指标证实了开发过程的绿色凭证.
结论:
- 开发的方法提供了一个可持续和高效的替代方案,用于塔克林合成.
- 使用DES代表了绿色化学在药物开发中的重大进步.
- 新型塔克林衍生物在治疗应用方面表现有前途,具有更好的安全性.
相关概念视频
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.1K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.1K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
558
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
558
Sharpless Epoxidation
4.0K
The conversion of allylic alcohols into epoxides using the chiral catalyst was discovered by K. Barry Sharpless and is known as Sharpless epoxidation. The use of a chiral catalyst enables the formation of one enantiomer of the product in excess. This chiral catalyst is mainly a chiral complex of titanium tetraisopropoxide and tartrate ester (specific stereoisomer). The stereoisomer used in the chiral catalyst dictates the formation of the enantiomer of the product. In other words, the use of...
4.0K

